Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

446 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia.
Barreyro L, Sampson AM, Ishikawa C, Hueneman KM, Choi K, Pujato MA, Chutipongtanate S, Wyder M, Haffey WD, O'Brien E, Wunderlich M, Ramesh V, Kolb EM, Meydan C, Neelamraju Y, Bolanos LC, Christie S, Smith MA, Niederkorn M, Muto T, Kesari S, Garrett-Bakelman FE, Bartholdy B, Will B, Weirauch MT, Mulloy JC, Gul Z, Medlin S, Kovall RA, Melnick AM, Perentesis JP, Greis KD, Nurmemmedov E, Seibel WL, Starczynowski DT. Barreyro L, et al. Among authors: kesari s. Sci Transl Med. 2022 Mar 9;14(635):eabb7695. doi: 10.1126/scitranslmed.abb7695. Epub 2022 Mar 9. Sci Transl Med. 2022. PMID: 35263148
Pritumumab, the first therapeutic antibody for glioma patients.
Babic I, Nurmemmedov E, Yenugonda VM, Juarez T, Nomura N, Pingle SC, Glassy MC, Kesari S. Babic I, et al. Among authors: kesari s. Hum Antibodies. 2018 Feb 5;26(2):95-101. doi: 10.3233/HAB-170326. Hum Antibodies. 2018. PMID: 29036806 Review.
Wnt pathway: a hallmark of drug discovery challenge.
Babic I, Yenugonda VM, Kesari S, Nurmemmedov E. Babic I, et al. Among authors: kesari s. Future Med Chem. 2018 Jun 1;10(12):1399-1403. doi: 10.4155/fmc-2018-0084. Epub 2018 May 21. Future Med Chem. 2018. PMID: 29779411 No abstract available.
Cellular target engagement: a new paradigm in drug discovery.
Babic I, Kesari S, Nurmemmedov E. Babic I, et al. Among authors: kesari s. Future Med Chem. 2018 Jul 1;10(14):1641-1644. doi: 10.4155/fmc-2018-0139. Epub 2018 Jun 29. Future Med Chem. 2018. PMID: 29957028 No abstract available.
Antibody drug conjugates: Progress, pitfalls, and promises.
Mukherjee A, Waters AK, Babic I, Nurmemmedov E, Glassy MC, Kesari S, Yenugonda VM. Mukherjee A, et al. Among authors: kesari s. Hum Antibodies. 2019;27(1):53-62. doi: 10.3233/HAB-180348. Hum Antibodies. 2019. PMID: 30223393 Review.
446 results